Skip to main content
Log in

Feasibility, safety and accuracy of regadenoson–atropine (REGAT) stress echocardiography for the diagnosis of coronary artery disease: an angiographic correlative study

  • Original Paper
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

Abstract

Regadenoson (REG), a selective A2A receptor vasodilator, has not been widely evaluated in stress echocardiography (SE). We report results of 45 patients participating in REG + atropine (REGAT) SE protocol conducted in a single-center prospective trial. The REGAT study enrolled subjects before a clinically indicated cardiac catheterization for suspected coronary artery disease (CAD). After rest imaging, a 2 mg Atropine (AT) bolus followed by 400 mcg of REG was given. Standard stress imaging views were obtained and interpreted in blinded fashion. Sensitivity, specificity, positive and negative predictive values (PPV, NPV) were calculated using cardiac catheterization >70 % stenosis as gold standard. Additional endpoints included major adverse cardiac events (MACE) and patient questionnaire responses. The mean duration of REGAT was 18 ± 7.2 min. There were no MACE, with only transient side-effects of dry mouth, shortness of breath, and headache. The incidence of significant CAD was 51.1 %. The sensitivity and specificity for significant stenosis was 60.9 and 86.4 %, with a PPV and NPV of 82.4 and 67.9 %. By coronary territories, the sensitivity, specificity, PPV, and NPV were: left anterior descending artery 58.8, 92.9, 83.3, and 78.8 %; left circumflex artery 6.7, 93.3, 33.3, and 67.7 %; and right coronary artery 16.7, 93.9, 50, and 75.6 %. Over 90 % of subjects reported feeling comfortable, with 83 % preferring REGAT as a future stress modality. The REGAT protocol is fast, safe, and well-tolerated with good specificity for CAD detection, but its low sensitivity and NPV precludes it from being an imaging modality for routine use.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Salustri A, Fioretti PM, McNeill AJ, Pozzoli MM, Roelandt JR (1992) Pharmacological stress echocardiography in the diagnosis of coronary artery disease and myocardial ischaemia: a comparison between dobutamine and dipyridamole. Eur Heart J 13:1356–1362

    CAS  PubMed  Google Scholar 

  2. Picano E, Bedetti G, Varga A, Cseh E (2000) The comparable diagnostic accuracies of dobutamine-stress and dipyridamole-stress echocardiographies: a meta-analysis. Coron Artery Dis 11:151–159

    Article  CAS  PubMed  Google Scholar 

  3. Astarita C, Palinkas A, Nicolai E, Maresca FS, Varga A, Picano E (2001) Dipyridamole-atropine stress echocardiography versus exercise SPECT scintigraphy for detection of coronary artery disease in hypertensives with positive exercise test. J Hypertens 19:495–502

    Article  CAS  PubMed  Google Scholar 

  4. Scherhag AW, Pfleger S, Schreckenberger AB, Gruttner J, Voelker W, Staedt U, Heene DL (1997) Detection of patients with restenosis after PTCA by dipyridamole-atropine-stress-echocardiography. Int J Card Imaging 13:115–123

    Article  CAS  PubMed  Google Scholar 

  5. Lanzarini L, Fetiveau R, Poli A, Diotallevi P, Barberis P, Previtali M (1995) Results of dipyridamole plus atropine echo stress test for the diagnosis of coronary artery disease. Int J Card Imaging 11:233–240

    Article  CAS  PubMed  Google Scholar 

  6. Fukai T, Koyanagi S, Tashiro H, Ichiki T, Tsutsui H, Matsumoto T, Takeshita A (1995) Adenosine triphosphate stress echocardiography in the detection of myocardial ischemia. Am J Card Imaging 9:237–244

    CAS  PubMed  Google Scholar 

  7. Tawa CB, Baker WB, Kleiman NS, Trakhtenbroit A, Desir R, Zoghbi WA (1996) Comparison of adenosine echocardiography, with and without isometric handgrip, to exercise echocardiography in the detection of ischemia in patients with coronary artery disease. J Am Soc Echocardiogr 9:33–43

    Article  CAS  PubMed  Google Scholar 

  8. Iskandrian AE, Bateman TM, Belardinelli L, Blackburn B, Cerqueira MD, Hendel RC, Lieu H, Mahmarian JJ, Olmsted A, Underwood SR, Vitola J, Wang W (2007) Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol 14:645–658

    Article  PubMed  Google Scholar 

  9. Mahmarian JJ, Cerqueira MD, Iskandrian AE, Bateman TM, Thomas GS, Hendel RC, Moye LA, Olmsted AW (2009) Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial. JACC Cardiovasc Imaging 2:959–968

    Article  PubMed  Google Scholar 

  10. Cerqueira MD, Nguyen P, Staehr P, Underwood SR, Iskandrian AE (2008) Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results. JACC Cardiovasc Imaging 1:307–316

    Article  PubMed  Google Scholar 

  11. Takeishi Y, Chiba J, Abe S, Ikeda K, Tomoike H (1994) Adenosine-echocardiography for the detection of coronary artery disease. J Cardiol 24:1–7

    CAS  PubMed  Google Scholar 

  12. Harada M, Okura K, Nishizawa S, Inoue T, Sakai H, Lee T, Sugiyama Y, Suzuki M, Hirai H, Yamaguchi T (1998) Detection of coronary artery disease by adenosine triphosphate stress echocardiography: comparison with adenosine triphosphate stress thallium myocardial scintigraphy and coronary angiography. J Cardiol 32:163–171 (in Japanese)

    CAS  PubMed  Google Scholar 

  13. Picano E, Pingitore A, Conti U, Kozakova M, Boem A, Cabani E, Ciuti M, Distante A, L’Abbate A (1993) Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dipyridamole echocardiography. Eur Heart J 14:1216–1222

    Article  CAS  PubMed  Google Scholar 

  14. Henzlova MJ, Cerqueira MD, Mahmarian JJ, Yao SS (2006) Stress protocols and tracers. J Nucl Cardiol 13:e80–e90

    Article  PubMed  Google Scholar 

  15. Ranhosky A, Kempthorne-Rawson J (1990) The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Intravenous Dipyridamole Thallium Imaging Study Group. Circulation 81:1205–1209

    Article  CAS  PubMed  Google Scholar 

  16. Mulvagh SL, Rakowski H, Vannan MA, Abdelmoneim SS, Becher H, Bierig SM, Burns PN, Castello R, Coon PD, Hagen ME, Jollis JG, Kimball TR, Kitzman DW, Kronzon I, Labovitz AJ, Lang RM, Mathew J, Moir WS, Nagueh SF, Pearlman AS, Perez JE, Porter TR, Rosenbloom J, Strachan GM, Thanigaraj S, Wei K, Woo A, Yu EH, Zoghbi WA (2008) American Society of Echocardiography consensus statement on the clinical applications of ultrasonic contrast agents in echocardiography. J Am Soc Echocardiogr 21:1179–1201

    Article  PubMed  Google Scholar 

  17. Pellikka PA, Nagueh SF, Elhendy AA, Kuehl CA, Sawada SG (2007) American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr 20:1021–1041

    Article  PubMed  Google Scholar 

  18. Bartunek J, Marwick TH, Rodrigues AC, Vincent M, Van Schuerbeeck E, Sys SU, de Bruyne B (1996) Dobutamine-induced wall motion abnormalities: correlations with myocardial fractional flow reserve and quantitative coronary angiography. J Am Coll Cardiol 27:1429–1436

    Article  CAS  PubMed  Google Scholar 

  19. Iskandrian AS, Verani MS, Heo J (1994) Pharmacologic stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease. J Nucl Cardiol 1:94–111

    Article  CAS  PubMed  Google Scholar 

  20. Chan SY, Brunken RC, Czernin J, Porenta G, Kuhle W, Krivokapich J, Phelps ME, Schelbert HR (1992) Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol 20:979–985

    Article  CAS  PubMed  Google Scholar 

  21. Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD (1990) Effects of adenosine on human coronary arterial circulation. Circulation 82:1595–1606

    Article  CAS  PubMed  Google Scholar 

  22. Voudris V, Manginas A, Vassilikos V, Koutelou M, Kantzis J, Cokkinos DV (1996) Coronary flow velocity changes after intravenous dipyridamole infusion: measurements using intravascular Doppler guide wire. A documentation of flow inhomogeneity. J Am Coll Cardiol 27:1148–1155

    Article  CAS  PubMed  Google Scholar 

  23. Picano E, Marini C, Pirelli S, Maffei S, Bolognese L, Chiriatti G, Chiarella F, Orlandini A, Seveso G, Colosso MQ et al (1992) Safety of intravenous high-dose dipyridamole echocardiography. The Echo-Persantine International Cooperative Study Group. Am J Cardiol 70:252–258

    Article  CAS  PubMed  Google Scholar 

  24. Sicari R, Pasanisi E, Venneri L, Landi P, Cortigiani L, Picano E (2003) Stress echo results predict mortality: a large-scale multicenter prospective international study. J Am Coll Cardiol 41:589–595

    Article  PubMed  Google Scholar 

  25. Coletta C, Galati A, Greco G, Burattini M, Ricci R, Carunchio A, Fera MS, Bordi L, Ceci V (1995) Prognostic value of high dose dipyridamole echocardiography in patients with chronic coronary artery disease and preserved left ventricular function. J Am Coll Cardiol 26:887–894

    Article  CAS  PubMed  Google Scholar 

  26. Pingitore A, Picano E, Colosso MQ, Reisenhofer B, Gigli G, Lucarini AR, Petix N, Previtali M, Bigi R, Chiaranda G, Minardi G, de Alcantara M, Lowenstein J, Sclavo MG, Palmieri C, Galati A, Seveso G, Heyman J, Mathias W Jr, Casazza F, Sicari R, Raciti M, Landi P, Marzilli M (1996) The atropine factor in pharmacologic stress echocardiography. Echo Persantine (EPIC) and Echo Dobutamine International Cooperative (EDIC) Study Groups. J Am Coll Cardiol 27:1164–1170

    Article  CAS  PubMed  Google Scholar 

  27. Cortigiani L, Picano E, Landi P, Previtali M, Pirelli S, Bellotti P, Bigi R, Magaia O, Galati A, Nannini E (1998) Value of pharmacologic stress echocardiography in risk stratification of patients with single-vessel disease: a report from the Echo-Persantine and Echo-Dobutamine International Cooperative Studies. J Am Coll Cardiol 32:69–74

    Article  CAS  PubMed  Google Scholar 

  28. Pingitore A, Picano E, Varga A, Gigli G, Cortigiani L, Previtali M, Minardi G, Colosso MQ, Lowenstein J, Mathias W Jr, Landi P (1999) Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: a prospective, large-scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test. Echo-Persantine International Cooperative (EPIC) and Echo-Dobutamine International Cooperative (EDIC) Study Groups. J Am Coll Cardiol 34:1769–1777

    Article  CAS  PubMed  Google Scholar 

  29. Cortigiani L, Lombardi M, Michelassi C, Paolini EA, Nannini E (1998) Significance of myocardial ischemic electrocardiographic changes during dipyridamole stress echocardiography. Am J Cardiol 82:1008–1012

    Article  CAS  PubMed  Google Scholar 

  30. Marwick T, Willemart B, D’Hondt AM, Baudhuin T, Wijns W, Detry JM, Melin J (1993) Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Comparison of dobutamine and adenosine using echocardiography and 99mTc-MIBI single photon emission computed tomography. Circulation 87:345–354

    Article  CAS  PubMed  Google Scholar 

  31. Kim C, Kwok YS, Heagerty P, Redberg R (2001) Pharmacologic stress testing for coronary disease diagnosis: a meta-analysis. Am Heart J 142:934–944

    Article  CAS  PubMed  Google Scholar 

  32. Gordi T, Blackburn B, Lieu H (2007) Regadenoson pharmacokinetics and tolerability in subjects with impaired renal function. J Clin Pharmacol 47:825–833

    Article  CAS  PubMed  Google Scholar 

  33. Porter TR, Adolphson M, High RR, Smith LM, Olson J, Erdkamp M, Xie F, O’Leary E, Wong BF, Eifert-Rain S, Hagen ME, Abdelmoneim SS, Mulvagh SL (2011) Rapid detection of coronary artery stenoses with real-time perfusion echocardiography during regadenoson stress. Circ Cardiovasc Imaging 4:628–635

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was investigator initiated and funded by Astellas Pharma US, Inc. We thank Stephanie Stebens MLIS from Sladen Library Henry Ford Hospital for her expert assistance formatting the manuscript.

Conflict of interest

Dr Ananthasubramaniam receives research grants from Astellas Pharma US Inc.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karthik Ananthasubramaniam.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shaikh, K., Wang, D.D., Saad, H. et al. Feasibility, safety and accuracy of regadenoson–atropine (REGAT) stress echocardiography for the diagnosis of coronary artery disease: an angiographic correlative study. Int J Cardiovasc Imaging 30, 515–522 (2014). https://doi.org/10.1007/s10554-014-0363-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-014-0363-6

Keywords

Navigation